Skip to content
🌐 Global🇮🇳 India📍 Asia-Pacific📍 Bihar📍 Delhi-NCR📍 East India📍 Europe📍 Gujarat📍 Karnataka📍 Kerala📍 Madhya Pradesh📍 Maharashtra📍 Middle East📍 North India📍 Northeast India📍 Punjab📍 Rajasthan📍 South India📍 Tamil Nadu📍 Telangana📍 United Kingdom📍 United States📍 Uttar Pradesh📍 West Bengal📍 West India
LIVE
Home / Science
Science

Molecular Mapping Unlocks Near-Atomic Structure of Survival Machinery in Tropical Parasites

Researchers from the University of Liège and Rockefeller University have resolved the three-dimensional structure of a gigantic molecular machine vital to trypanosomatid parasites. The breakthrough provides structural biologists with a precise blueprint for targeting neglected tropical diseases.

Phys.org ScienceSeptember 23, 20261 min read
Share this story
Molecular Mapping Unlocks Near-Atomic Structure of Survival Machinery in Tropical Parasites
The Strategic Consequence
High-resolution structural mapping of parasite machinery will shift neglected disease drug discovery toward AI-driven computational inhibitor design over the next five years.

Utilizing advanced cryogenic electron microscopy, the research team captured near-atomic snapshots of the macromolecular assembly responsible for RNA editing within trypanosomes. These parasites cause debilitating conditions such as sleeping sickness and Chagas disease, affecting millions across tropical regions. Understanding the exact mechanical geometry of this survival machinery has eluded scientists for decades due to its immense cellular complexity. The scientific bottleneck had long centered on the difficulty of stabilizing giant protein-RNA complexes outside their native cellular environment without disrupting their functional architecture. By overcoming these biochemical hurdles, the investigators revealed previously unknown cavities within the molecular motor that can potentially accommodate small-molecule inhibitors. This discovery bridges the gap between fundamental structural biology and targeted drug design. The tangible outcome will be the accelerated development of selective therapeutic compounds that disrupt parasite survival without harming human host cells. Downstream, pharmaceutical developers gain a viable pathway to revive drug pipelines for neglected tropical diseases historically underserved by commercial research markets. This structural biology milestone opens the door to rational drug design for pathogen classes previously deemed undruggable.

📰 Primary Source Publication Verified Resource & Provenance
The Next Brief
Get the day's most important stories in one email
AI-curated morning digest. No noise. Unsubscribe anytime.

Comments 0

Advertisement

Related stories

Most read

  1. 1Lack of hygienic menstrual shelters posing health risk to tribal womenPolitics
  2. 2Will Trump's AI rebrand as 'super intelligence' catch on?Technology
  3. 3IIT-Bombay student death: Parents allege he faced casteist abuse, demand arrest of faculty memberPolitics
  4. 4OpenAI wants to consult elite mathematicians about how to not fumble againTechnology
  5. 5Will a switch to light speed cut power use at data centres?Technology